ESR1 and breast carcinoma: ER activation is considered an important factor in breast cancer progression [26], whereas treatment with anti-estrogen chemotherapy drugs (e.g., tamoxifen) can reduce the growth of cultures by inhibiting proliferation and inducing apoptosis [27].